Levocetirizine Teva Uk

Levocetirizine, the active ingredient in Levocetirizine Teva Uk, is a H1 receptor antagonist presented as an oral tablet for systemic use. It is employed to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults, adolescents and children over six years of age.

GNH USA supplies Levocetirizine Teva Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery to diverse healthcare settings.

Levocetirizine is used to manage allergic conditions that involve histamine release.

- Allergic rhinitis: reduces nasal congestion, sneezing, and itching. - Chronic idiopathic urticaria: alleviates hives and associated itching. - Allergic conjunctivitis: eases eye itching and redness.

Levocetirizine may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Fatigue: feeling of tiredness. - Dry mouth: reduced salivation. - Headache: mild cranial pain. - Nausea: upset stomach. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, or throat. - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin rash. - Tachycardia: rapid heart rate. - Hepatic dysfunction: abnormal liver enzymes. - Blood dyscrasias: abnormal blood cell counts.

Before using Levocetirizine, consider the following precautions.

- Pregnancy: consult a healthcare provider; safety not established. - Breastfeeding: may be excreted in milk; weigh benefits against risks. - Renal impairment: dose adjustment may be required. - Elderly: increased sensitivity to sedation. - Alcohol: avoid or limit as it may enhance drowsiness. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Levocetirizine can interact with other medicines.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Other antihistamines: risk of excessive sedation. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma levels. - Ritonavir: can raise drug concentrations. - Monoamine oxidase inhibitors: potential additive effects.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, opioids): monitor for enhanced sedation. - Theophylline: may increase its plasma concentration. - Diuretics: possible potentiation of antihistamine effect. - Anticholinergic drugs: additive dry‑mouth. - Vaccines: may slightly reduce immune response.